Many of the directions included in the order will be familiar to those who watched drug pricing policy closely during the ...

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer’s disease (early AD) ...

British pharmaceutical giant GSK has not met required ethical and regulatory standards in the marketing and prescription ...

For decades, treatment options for rare diseases have been limited, often focusing on symptom management rather than ...

Medical affairs teams produce evidence-based, non-promotional scientific content for healthcare professionals (HCPs), while ...

Medical affairs can no longer afford to operate within legacy structures. Enter AI-enabled functional service provider (FSP) models that offer operational relief.

Ex-vaccine regulator Peter Marks promoted "ineffective therapy that gave patients false hope, eroded trust in the regulatory ...

Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon ...

Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving ...

The Pharmaceutical Society of Ghana (PSGH) has rescheduled the maiden PSGH Pharma Excellence Awards to April 11, 2025.This has become necessary because of the large volume of entries received and ...

In this article, we are going to take a look at where BioMarin Pharmaceutical Inc. (NASDAQ ... financial metrics, and the US regulatory landscape significantly impact the industry.

Reporting zero taxable profits in the U.S. in 2019, Pfizer (NYSE:PFE) carried out possibly the largest tax-avoidance scheme in the history of Big Pharma, Senator Ron Wyden (D-Ore.) said on Thursday.